非小细胞肺癌患者PD-1通路抑制剂客观缓解率低与EGFR突变或ALK阳性有关
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer
非小细胞肺癌患者PD-1通路抑制剂客观缓解率低与EGFR突变或ALK阳性有关 |
|
评价者：胡毅 |
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer |
| |